Global Med Technologies(R), Inc. and Stanford University Medical Center Sign Contract for Transfusion Management System Stanford Selects SafeTrace Tx(R) Advanced Transfusion Management System DENVER, Oct. 8 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med"), announced the signing of an agreement for its SafeTrace Tx(R)* advanced transfusion management system with Stanford University Medical Center. This contract will make Stanford the largest SafeTrace Tx client on the West coast. Terms were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Susie Lu, VP of Pathology and Laboratory Medicine at Stanford Hospital and Clinics and Lucile Packard Children's Hospital, said, "Our clinical staff selected Wyndgate's SafeTrace Tx transfusion management system for its comprehensive safety features, as well as its integration capabilities, which will facilitate the automation of many of the paper processes currently in use in our transfusion service." Ms. Lu added, "Wyndgate, with its expertise in the blood bank industry, has successfully developed software to manage the complexities of both the transfusion service and the donor facility. As Stanford Medical School Blood Center currently uses Wyndgate's SafeTrace Donor Management System, the Stanford Transfusion Service Laboratory will benefit from the enhanced efficiencies that come with having linked software systems." Thomas F. Marcinek, President and COO of Global Med Technologies, Inc., stated, "We are very pleased to announce this major agreement with Stanford University Medical Center, a prestigious academic research facility, recognized internationally for its excellence in healthcare." Mr. Marcinek added, "Our partnership with Stanford highlights Wyndgate's commitment to quality and safety by automating the management of the blood transfusion cycle from collection to transfusion, safely and efficiently." About Stanford University Medical Center Stanford University Medical Center is known worldwide for the advanced patient care provided by its staff, for the treatment of rare, complex disorders such as cardiac care, cancer treatment, neurology, neurosurgery and organ transplants. Stanford University Medical Center and its physicians consistently rank among the top in the nation in surveys by consumers and health care professionals and in July, 2002, was named to the Honor Roll of America's Best Hospitals by U.S. News & World Report. For more information about Stanford University Medical Center and its three institutions (Stanford Hospital and Clinics, Lucile Packard Children's Hospital and Stanford University School of Medicine), visit its website at http://www.stanfordhospital.com/. About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R), Inc. CONTACT: Press, Patti Larson, Senior Director of Marketing Development, +1-916-404-8492, ; or Investors, Tom Marcinek, President and COO, +1-916-404-8413, , all of Wyndgate Technologies Web site: http://www.stanfordhospital.com/ Web site: http://www.peoplemed.com/ http://www.wyndgate.com/ http://www.globalmedtech.com/

Copyright